Technical

Technical — what the tape is saying

Blue Moon trades at HK$2.96, sub-200-day, in the bottom quartile of its 52-week range, and roughly 85% below its January-2021 IPO-week peak. The price action confirms the fundamental picture from the Numbers tab — two years of operating losses have coincided with a secular downtrend — but a short-term MACD bounce off the November 2025 low means the next 60 trading days are not a layup for the bears either. This is a neutral-leaning-bearish setup waiting for either a reclaim of the 200-day (~HK$3.16) or a loss of the 52-week floor (HK$2.50).

1. Price snapshot

2. Five years of price — the secular downtrend is the story

The 5-year story is two regime shifts. From the Dec-2020 IPO to late 2023, price compounded a near-vertical decline from HK$19 to HK$1.7. The golden cross in September 2024 signalled a reclaim attempt that peaked at HK$4.34 in June 2025. Since then the death cross, the breakdown below both moving averages, and a lower-high / lower-low structure in 2026 all point the same direction: still a downtrend, with a late-stage bounce in progress.

3. Relative strength — three years of underperformance, still widening

Over three years an investor in Blue Moon is down 34%; in SPY, up 79%. The gap is 113 percentage points and still widening — the post-Sept-2024 rally briefly looked like a catch-up trade but stalled below the rebased SPY line and has since rolled over. No China-sector ETF is included because coverage isn't available for this name; the SPY comparison is the global opportunity-cost yardstick, not a sector read.

4. Momentum — short-term improving, context still soft

RSI is 58 — firmly neutral, but the direction matters. The indicator printed 29.9 at the early-November low and has climbed back to the mid-50s / low-60s since, and the MACD histogram has been in positive territory since late-March after flipping from a March drawdown. Momentum is the most constructive box on this page; it's the reason this is not a straight-short setup. Neither indicator is at an extreme — RSI is nowhere near overbought, MACD histogram is small. The signal is "dip being bought", not "breakout underway".

5. Volume & conviction — the September 2025 climax, then silence

The September 2025 spike is the set-piece event: four consecutive sessions of 7–22x average volume, culminating on 18-Sep with 116.7M shares changing hands (21.9x). Price was already weakening into that window and the cluster preceded the 50/200 death cross one week later — that is volume confirming distribution, not accumulation. Since then the 50-day average volume has collapsed from 7M back to 1.3M, and the current bounce is happening on about 1x average — a thin tape with little conviction either way.

6. Volatility — back inside the normal band

Realized vol sits at 38% — squarely in the "normal" band between the 5-year p20 (29%) and p80 (50%). The spikes around the Oct–Nov 2024 squeeze (88%) and the April 2022 drawdown (72%) mark the two stressed regimes in the sample; today's reading is not one of them. For a HK$17B-market-cap Hong Kong staple, 38% is elevated but unremarkable — the market is not pricing in a tail event right now.

7. Scorecard + stance

Stance (3–6 months): neutral-to-bearish. The weight of evidence — sub-200-day price, three-year relative-strength rout, distribution-style volume signature into the September death cross — is bearish, but an RSI turn off 30 and a positive MACD histogram keep a re-test of the 200-day on the table before any fresh breakdown. The cross-reference with the Numbers tab is unambiguous: the price action confirms the fundamental concern (two years of operating losses, S&D ratio at 53%) and nothing in the tape is yet pointing to the rerate catalyst that a falling S&D ratio would produce. Bull confirmation: sustained close above HK$3.50 (which reclaims the 200d at HK$3.16 and breaks the August–September 2025 swing highs). Bear confirmation: close below HK$2.50 (which loses the 52-week low and opens the path to the 2024 low near HK$1.68).